Michael Grissinger

This profile gathers the share dealings of Michael Grissinger in Aprea Therapeutics, Inc. The record holds 5 filings, for trades running from 28 July 2022 to 16 June 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 17 June 2026, the filings show a share grant in Aprea Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.